scorecardresearch
Saturday, November 2, 2024
TopicPharmaceutical companies

Topic: Pharmaceutical companies

High demand, strict inspections — how Biden’s presidency could impact India’s pharma sector

US is the biggest market for Indian pharmaceutical companies and Biden's presidency is expected to bring with it some favourbable changes that could have a long-ranging impact.

Govt repeats warning to pharma firms, says don’t ‘promote products in unethical ways’

In a letter to pharma organisations, govt mentioned a complaint against an event to be held by ‘Indian Psychotropic Society’. Industry members say they have never heard the name.

US FDA warns pharma giant Mylan over poor quality control at its Telangana plant

US FDA inspected Mylan’s plant in Pashamylaram, Telangana, and found it hadn’t taken proper precautions to ensure solvents didn’t contain impurities.

Modi govt to form standing committee to prevent drugmakers from evading price control

Representatives from NPPA, CDSCO and DGHS to be part of the standing committee, which will have mandate to approve the drug discontinuation applications.

Glenmark’s favipiravir under govt scanner for ‘false claims’, cost, DCGI seeks clarification

Complaint by MP to DCGI  also highlights that the cost proposed by Glenmark is ‘definitely not in the interest of the poor, lower middle class and middle-class people of India’.

2 die at pharma plant after Vizag sees another gas leak in less than 2 months

Four people were hospitalised after benzene gas leaked at the Sainor Life Sciences company. The cause of the leak is yet to be determined.

Indian drugmaker Lupin voluntarily recalls metformin variant, a diabetes drug, in US

India has said it is monitoring the US FDA updates, which said an extended-release variant of the drug had higher levels of a cancer-causing substance.

AstraZeneca-Gilead deal might not actually happen, say analysts

Political opposition from both Britain and America could derail any attempt at a deal, especially given the backdrop of the Covid-19 outbreak.

Big pharma is looking beyond coronavirus with AstraZeneca eyeing merger with Gilead

The suggestion of a blockbuster merger between the two drugmakers is a sign that the industry is getting back to something resembling business as usual.

Don’t distract doctors with online promotion of brands amid Covid: Modi govt to pharma firms

Order does not clarify what kind of promotions should not be done. Pharma lobbies said they would reach out to govt for clarification.

On Camera

As a Hindu Canadian, I am deeply hurt by cancellation of Diwali. My community is now sidelined

Canada faces serious foreign interference issues, but these challenges must not be weaponized to unfairly target friendly and important allies like India.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

All about Major Bob Khathing, whose daring expedition & diplomatic parleys secured Tawang for India

The decorated Naga officer from Manipur also served as envoy to Myanmar & Nagaland chief secy. Defence Minister Rajnath Singh inaugurated a museum dedicated to the Tawang hero Thursday.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.